PR
Protect Pharmaceutical Corporation
PRTT · OTC
$0.15 -9.64% (-$0.02)
1M -16.67%
Market Cap $25.9M
P/E Ratio 0.52x
Div. Yield -
ROE 14.71%
Bulios Fair Price
$0.19
26.7% upside
Current Price
$0.15
Undervalued Fair Value Overvalued
According to Bulios Fair Price, PRTT is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/FCF 9.62x
P/E 0.52x
P/B 0.07x
Growth
100 /100
Growing Book val. growth 17.39%
EPS growth 39.63%
Rev. growth 18.84%
Profitability
76 /100
Strong Op. margin 44.24%
Gross margin 59.61%
FCF margin 2.39%
Quality
67 /100
Excellent ROA 11.66%
ROIC 12.98%
Asset turnover 0.27x
Debt
100 /100
Low Net debt/EBITDA -0.31x
Debt/Equity 0.01x
Current ratio 3.37x
Stability
31 /100
Unstable EPS volatility 37.60%
Beta 2.21x
Profitable years 4
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PRTT
Online
Sector
Industrials
Industry
Airlines, Airports & Air Services
CEO
Boris Stepanov
Employees
600
Headquarters
Las Vegas